Curexo Inc (060280) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.016x

Based on the latest financial reports, Curexo Inc (060280) has a cash flow conversion efficiency ratio of -0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.49 Billion ≈ $-1.01 Million USD) by net assets (₩94.30 Billion ≈ $63.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Curexo Inc stock valuation for the company's overall valuation and market capitalisation.

Curexo Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Curexo Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Curexo Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Curexo Inc ranked by their cash flow conversion efficiency. Explore Curexo Inc cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Consumer Portfolio Services Inc NASDAQ:CPSS	0.276x
Mayer Steel Pipe Corp TW:2020	0.070x
AROBS TRANSILVANIA SOFTWARE SA RO:AROBS	0.032x
H&R GmbH & Co. KGaA XETRA:2HRA	0.054x
Hup Seng Industries Bhd KLSE:5024	0.135x
Universal Microelectronics Co Ltd TW:2413	0.066x
Zhejiang Zone King Environmental Sci&Tech Co Ltd SHG:688701	0.069x
Southern Silver Exploration Corp. V:SSV	-0.024x

Annual Cash Flow Conversion Efficiency for Curexo Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Curexo Inc from 2012 to 2024. View today's stock price for Curexo Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩93.38 Billion ≈ $63.28 Million	₩3.85 Billion ≈ $2.61 Million	0.041x	-18.50%
2023-12-31	₩100.43 Billion ≈ $68.06 Million	₩5.08 Billion ≈ $3.44 Million	0.051x	+131.58%
2022-12-31	₩81.68 Billion ≈ $55.35 Million	₩-13.08 Billion ≈ $-8.87 Million	-0.160x	+21.40%
2021-12-31	₩42.90 Billion ≈ $29.07 Million	₩-8.74 Billion ≈ $-5.92 Million	-0.204x	-496.60%
2020-12-31	₩44.79 Billion ≈ $30.36 Million	₩-1.53 Billion ≈ $-1.04 Million	-0.034x	+70.40%
2019-12-31	₩43.98 Billion ≈ $29.80 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.115x	+46.85%
2018-12-31	₩70.03 Billion ≈ $47.46 Million	₩-15.20 Billion ≈ $-10.30 Million	-0.217x	-911.18%
2017-12-31	₩70.69 Billion ≈ $47.91 Million	₩-1.52 Billion ≈ $-1.03 Million	-0.021x	+97.33%
2016-12-31	₩73.08 Billion ≈ $49.53 Million	₩-58.79 Billion ≈ $-39.84 Million	-0.804x	-36.21%
2015-12-31	₩33.51 Billion ≈ $22.71 Million	₩-19.79 Billion ≈ $-13.41 Million	-0.591x	+58.96%
2014-12-31	₩13.94 Billion ≈ $9.45 Million	₩-20.06 Billion ≈ $-13.60 Million	-1.439x	-246.31%
2013-12-31	₩35.09 Billion ≈ $23.78 Million	₩-14.58 Billion ≈ $-9.88 Million	-0.416x	-4.98%
2012-12-31	₩49.48 Billion ≈ $33.53 Million	₩-19.59 Billion ≈ $-13.27 Million	-0.396x	--

About Curexo Inc

KQ:060280 Korea Food & Drug Retailing

Market Cap

$183.78 Million

₩271.19 Billion KRW

Market Cap Rank

#16993 Global

#656 in Korea

Share Price

₩8130.00

Change (1 day)

-0.25%

52-Week Range

₩7260.00 - ₩20350.00

All Time High

₩24400.00